(Q34871558)

5 August 2017

1 reference

title

A benefit-risk assessment of class III antiarrhythmic agents. (English)

1 reference

5 August 2017

author

Christian Torp-Pedersen

series ordinal

3

object named as

Christian Torp-Pedersen

1 reference

5 August 2017

5

Lars Køber

1 reference

5 August 2017

1

Bente Brendorp

1 reference

5 August 2017

Oledyg Pedersen

2

1 reference

5 August 2017

Naji Sahebzadah

series ordinal

4

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

25

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

847-865

1 reference

Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics

5 August 2017

cites work

1 reference

12 December 2020

A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm

1 reference

12 December 2020

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

12 December 2020

Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)

1 reference

12 December 2020

Electrophysiology and pharmacology of ibutilide

1 reference

12 December 2020

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

1 reference

12 December 2020

Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy

1 reference

12 December 2020

Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B

1 reference

12 December 2020

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

1 reference

12 December 2020

Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

1 reference

12 December 2020

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines a

1 reference

12 December 2020

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators

1 reference

12 December 2020

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

12 December 2020

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

1 reference

12 December 2020

Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology

1 reference

12 December 2020

1 reference

12 December 2020

Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

1 reference

12 December 2020

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

12 December 2020

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

12 December 2020

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

12 December 2020

Cellular and Ionic Mechanisms Underlying Erythromycin-Induced Long QT Intervals and Torsade de Pointes

1 reference

12 December 2020

D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?

1 reference

12 December 2020

Low penetrance in the long-QT syndrome: clinical impact

1 reference

12 December 2020

1 reference

12 December 2020

New advances in class III antiarrhythmic drug therapy

1 reference

12 December 2020

Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence

1 reference

12 December 2020

Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells

1 reference

12 December 2020

Cardiovascular drugs. Dofetilide

1 reference

12 December 2020

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

1 reference

12 December 2020

Controlled trial of sotalol for one year after myocardial infarction

1 reference

12 December 2020

Clinical differences between the newer antiarrhythmic agents

1 reference

12 December 2020

Dofetilide: a new class III antiarrhythmic agent

1 reference

12 December 2020

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

12 December 2020

Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes.

1 reference

12 December 2020

Mechanisms of action of class III agents and their clinical relevance.

1 reference

12 December 2020

Frequency-dependent electrophysiologic effects of amiodarone in humans

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

1 reference

12 December 2020

Immediate reproducibility of clinical and nonclinical forms of induced ventricular tachycardia

1 reference

12 December 2020

Pure class III antiarrhythmic drugs: focus on dofetilide

1 reference

12 December 2020

What niche will newer class III antiarrhythmic drugs occupy?

1 reference

12 December 2020

Modulation of potassium channels by antiarrhythmic and antihypertensive drugs

1 reference

12 December 2020

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

1 reference

12 December 2020

Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

1 reference

12 December 2020

Dofetilide, a new class III antiarrhythmic agent

1 reference

12 December 2020

Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing

1 reference

12 December 2020

Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol

1 reference

12 December 2020

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

12 December 2020

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

1 reference

12 December 2020

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

12 December 2020

Azimilide dihydrochloride: a new class III anti-arrhythmic agent

1 reference

12 December 2020

Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart

1 reference

12 December 2020

Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents

1 reference

12 December 2020

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation

1 reference

12 December 2020

Proarrhythmic responses during electrophysiologic testing

1 reference

12 December 2020

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

1 reference

12 December 2020

The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns

1 reference

12 December 2020

Dofetilide: a class III-specific antiarrhythmic agent

1 reference

12 December 2020

Acceleration-induced action potential prolongation and early afterdepolarizations

1 reference

12 December 2020

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death

1 reference

12 December 2020

The role of class III antiarrhythmic agents in maintaining sinus rhythm.

1 reference

12 December 2020

Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.

1 reference

12 December 2020

Taking the "idio" out of "idiosyncratic": predicting torsades de pointes

1 reference

12 December 2020

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

12 December 2020

Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachy

1 reference

12 December 2020

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

1 reference

12 December 2020

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

12 December 2020

The long QT syndrome: ion channel diseases of the heart

1 reference

12 December 2020

Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study

1 reference

12 December 2020

Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function

1 reference

12 December 2020

Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499

1 reference

12 December 2020

Expanding indications for the use of Class III agents in patients at high risk for sudden death

1 reference

12 December 2020

Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.

1 reference

12 December 2020

Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.

1 reference

12 December 2020

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

12 December 2020

Measurement, interpretation and clinical potential of QT dispersion.

1 reference

12 December 2020

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility

1 reference

12 December 2020

Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent

1 reference

12 December 2020

K+ Channel Blockade in the Prevention of Ventricular Fibrillation in Dogs with Acute Ischemia and Enhanced Sympathetic Activity

1 reference

12 December 2020

Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

1 reference

12 December 2020

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

12 December 2020

Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter

1 reference

12 December 2020

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators

1 reference

12 December 2020

What should we expect from the next generation of antiarrhythmic drugs?

1 reference

12 December 2020

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

1 reference

12 December 2020

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN

1 reference

12 December 2020

Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes.

1 reference

12 December 2020

Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians

1 reference

12 December 2020

Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone

1 reference

12 December 2020

Dofetilide (Tikosyn): a new drug to control atrial fibrillation.

1 reference

12 December 2020

Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group

1 reference

12 December 2020

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

1 reference

12 December 2020

The adrenergic antagonism of amiodarone

1 reference

12 December 2020

Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia

1 reference

12 December 2020

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

12 December 2020

Clinical potential of emerging antiarrhythmic agents

1 reference

12 December 2020

Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide

1 reference

12 December 2020

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

12 December 2020

Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart

1 reference

12 December 2020

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy

1 reference

12 December 2020

Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality

1 reference

12 December 2020

Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells

1 reference

12 December 2020

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

1 reference

12 December 2020

Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties

1 reference

12 December 2020

The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide.

1 reference

12 December 2020

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

1 reference

12 December 2020

Pause induced early afterdepolarizations in the long QT syndrome: a simulation study

1 reference

12 December 2020

Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation.

1 reference

12 December 2020

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

12 December 2020

Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy

1 reference

12 December 2020

Dofetilide: a new pure class III antiarrhythmic agent

1 reference

12 December 2020

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

1 reference

12 December 2020

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

1 reference

12 December 2020

QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure

1 reference

12 December 2020

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

12 December 2020

Dofetilide, a novel class III antiarrhythmic agent

1 reference

12 December 2020

Amiodarone versus quinidine in the prophylaxis of atrial fibrillation

1 reference

12 December 2020

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

12 December 2020

Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide

1 reference

12 December 2020

Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.

1 reference

12 December 2020

10.2165/00002018-200225120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1022649633

0 references

1 reference